Medindia

X

U.S. Preventive Medicine Appoints Ron Loeppke, M.D. as Co-Chairman of Its National Advisory Board

Tuesday, September 2, 2008 General News J E 4
Advertisement
DALLAS, Sept. 2 /PRNewswire/ - U.S. Preventive Medicine, Inc.(http://www.USPreventiveMedicine.com), the leader in disease prevention, hasannounced the appointment of Ron Loeppke, M.D., MPH, as Co-Chairman of thecompany's National Advisory Board. The Board is focused on researching therole of primary, secondary and tertiary prevention (health promotion, earlydetection and early intervention) in improving health and productivity in theworkplace, as well as in the home.

(Logo: http://www.newscom.com/cgi-bin/prnh/20080506/NETU129LOGO )

Dr. Ron Loeppke is the former Chief Strategic Officer and Executive VicePresident of Matria Healthcare, Inc. In this role he led the firm's strategicinitiatives across the company as well as provided counsel on medical, healthand productivity issues to Matria clients. Prior to joining Matria, Dr.Loeppke was Chief Medical Officer, Chief Strategic Officer, and Executive VicePresident for CorSolutions. Before CorSolutions, Ron was the Founder,President and CEO of the Health and Productivity Corporation of America(HPCA), headquartered in Brentwood, Tennessee.

Christopher Fey, Chairman and CEO of U.S. Preventive Medicine, said,"Having Ron serve as co-chair of our National Advisory Board is an excitingdevelopment in furthering the research agenda for U.S. Preventive Medicine.The Board will continue to research the areas in which primary, secondary andtertiary prevention can play a role in improving health outcomes andproductivity while reducing costs."

Dr. Loeppke is Board Certified and residency trained in PreventiveMedicine as well as fellowship trained in Occupational Medicine. He is aFellow of both the American College of Occupational and Environmental Medicine(ACOEM) and the American College of Preventive Medicine, (ACPM). He isCo-Chairman of the ACOEM Section on Health and Productivity, which is activelyinvolved in defining and establishing measurement criteria for research inhealth and productivity initiatives, as well as assimilating input frompractice experts in the field, employers, corporate medical directors,employer coalitions, pharmaceutical companies, the provider community, andother key stakeholders on the frontlines of the health and productivity arena.

Dr. Loeppke has over 20 years of clinical and physician executiveexperience in the Occupational Health, Preventive Medicine, and MedicalManagement arenas. He has authored numerous articles and book chaptersrelating to health and productivity, occupational health, managed care,quality care improvement, adoption of evidence based medicine, employer healthinitiatives, consumer driven healthcare, preventive medicine, and innovativemodels for the business of healthcare.

As the recent lead author of "Health and Productivity as a BusinessStrategy" in the Journal of Occupational and Environmental Medicine (JOEM),July 2007 issue, Dr. Loeppke and his fellow researchers demonstrated that thetotal cost of poor health far surpassed medical and pharmacy claims alone.The multi-employer based study determined two major results: 1) Health-relatedproductivity costs were more than four times greater than medical and pharmacycosts. 2) The full cost of poor health is driven by different healthconditions than those driving medical and pharmacy costs alone. The studydemonstrates that Integrated Population Health & Productivity Managementshould be built on a foundation of Integrated Population Health & ProductivityMeasurement. Therefore, employers should reveal a blueprint for action fortheir integrated health and productivity enhancement strategies by measuringthe full health and productivity costs related to the burdens of illness andhealth risk in their population.

About U.S. Preventive Medicine

U.S. Preventive Medicine(R), a privately-owned health management companywith clients nationwide and the United Kingdom, is focused entirely o
Advertisement


Advertisement

You May Also Like

Advertisement
View All

Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
User Avatar
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions
s
Ikaria(R) Acquires North American Rights to LUCASS...
S
Report Regarding the Managements' and Closely Rela...